V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20165602 | 20063479 | 1.65 | 77.8 | Neo-adjuvant (N) | null | 2017-11-19 | ECX | N | N | ECX | 100826715 |
| 20165606 | 20063480 | null | null | Palliative (P) | 2018-02-24 | 2018-03-17 | ECX | 02 | N | ECX | 101765242 |
| 20165612 | 20063481 | 1.72 | 110.1 | Palliative (P) | 2019-05-11 | 2019-05-12 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101042277 |
| 20165614 | 20063482 | 1.81 | 97.6 | Neo-adjuvant (N) | 2017-10-15 | 2017-10-22 | ECX | N | N | ECX | 100118651 |
| 20165616 | 20063483 | null | 76 | Palliative (P) | 2018-11-01 | 2018-11-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100892039 |
| 20165620 | 20063484 | 1.68 | 93.4 | Palliative (P) | 2017-05-01 | 2017-05-21 | ECX | N | N | ECX | 101467064 |
| 20165627 | 20063485 | 1.66 | 89.4 | Palliative (P) | 2016-09-25 | 2016-10-23 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101639935 |
| 20165630 | 20063486 | 1.77 | 61.6 | Adjuvant (A) | 2019-04-05 | 2019-05-03 | Gemcitabine + Capecitabine | null | N | CAPECITABINE + GEMCITABINE | 100346481 |
| 20165631 | 20063487 | 1.54 | 90.4 | Curative (C) | 2019-04-25 | 2019-04-26 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100968932 |
| 20165637 | 20063488 | 1.67 | 65.6 | Palliative (P) | 2018-03-09 | 2018-03-09 | ECX | N | N | ECX | 101030444 |
| 20165647 | 20063489 | 1.61 | null | Adjuvant (A) | 2017-06-19 | 2017-07-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101587180 |
| 20165650 | 20063490 | 1.63 | 60.6 | null | 2016-09-19 | 2016-10-08 | ECX | 02 | N | ECX | 100602810 |
| 20165658 | 20063491 | 1.6 | 73 | Curative (C) | 2018-04-14 | 2018-04-14 | ECX | 02 | N | ECX | 100642117 |
| 20165665 | 20063492 | 1.68 | 76 | Palliative (P) | 2018-12-22 | 2019-01-16 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100562425 |
| 20165671 | 20063493 | null | 93.55 | Palliative (P) | 2019-11-22 | 2019-12-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100990726 |
| 20165674 | 20063494 | null | null | Adjuvant (A) | 2017-01-04 | 2017-01-11 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101462284 |
| 20165677 | 20063495 | 1.65 | 50 | Adjuvant (A) | 2019-06-15 | 2019-06-27 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101204547 |
| 20165683 | 20063496 | 1.68 | 85 | 03 | 2019-03-07 | 2019-03-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100151015 |
| 20165686 | 20063497 | 1.62 | 58.3 | Adjuvant (A) | 2018-10-04 | 2018-10-13 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101480156 |
| 20165691 | 20063498 | 1.77 | 64.6 | Neo-adjuvant (N) | 2019-08-20 | 2019-08-20 | ECX | 02 | N | ECX | 100501817 |
| 20165707 | 20063499 | 1.54 | 66.2 | Adjuvant (A) | 2018-03-26 | 2018-03-26 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100247953 |
| 20165723 | 20063500 | 1.82 | 91 | Neo-adjuvant (N) | 2016-12-29 | 2016-12-30 | ECX | null | N | ECX | 100638913 |
| 20165733 | 20063501 | 1.77 | 64 | Palliative (P) | 2019-12-23 | 2019-12-30 | ECX | N | N | ECX | 100237138 |
| 20165739 | 20063502 | 1.56 | 82.05 | Palliative (P) | 2019-06-01 | 2019-06-19 | ECX | N | N | ECX | 100338549 |
| 20165746 | 20063503 | 1.8 | 64.4 | Curative (C) | 2016-07-21 | 2016-08-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100216121 |
| 20165750 | 20063504 | 1.6 | 52.8 | Palliative (P) | 2018-08-18 | 2018-08-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101767111 |
| 20165758 | 20063505 | 1.54 | 70.7 | Adjuvant (A) | 2018-11-27 | 2018-12-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100152822 |
| 20165761 | 20063506 | 1.67 | 62.3 | Palliative (P) | 2019-05-24 | 2019-06-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100036090 |
| 20165763 | 20063507 | 1.82 | 62 | Neo-adjuvant (N) | 2017-01-04 | 2017-01-18 | ECX | 02 | N | ECX | 100552765 |
| 20165770 | 20063508 | 1.73 | 54 | 02 | 2019-06-30 | 2019-06-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100556208 |
| 20165776 | 20063509 | 1.7 | 87.8 | Palliative (P) | 2018-08-01 | 2018-09-27 | ECX | 02 | N | ECX | 100648212 |
| 20165777 | 20063510 | 1.82 | 66.7 | Neo-adjuvant (N) | 2016-03-08 | 2016-03-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101187091 |
| 20165782 | 20063511 | 1.76 | 77 | 03 | 2016-09-23 | 2016-09-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101763191 |
| 20165787 | 20063512 | 1.5 | 54.4 | Neo-adjuvant (N) | 2017-06-19 | 2017-06-27 | ECX | 02 | N | ECX | 101172531 |
| 20165788 | 20063513 | 1.82 | 66 | null | 2018-06-27 | 2018-06-27 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100458304 |
| 20165794 | 20063514 | 1.61 | 56.2 | Palliative (P) | null | 2019-03-17 | Gemcitabine + Capecitabine | null | N | CAPECITABINE + GEMCITABINE | 100912020 |
| 20165796 | 20063515 | 1.6 | 84.4 | Palliative (P) | 2016-05-20 | 2016-06-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101346774 |
| 20165800 | 20063516 | 1.64 | 61 | Palliative (P) | 2019-05-15 | 2019-05-23 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100915556 |
| 20165803 | 20063517 | 1.79 | 66.75 | Neo-adjuvant (N) | 2016-12-17 | 2016-12-28 | ECX | N | N | ECX | 100160088 |
| 20165804 | 20063518 | null | null | Neo-adjuvant (N) | 2017-03-21 | 2017-03-26 | ECX | 2 | N | ECX | 101420889 |
| 20165811 | 20063519 | 1.71 | 86.9 | Palliative (P) | 2019-11-23 | 2019-11-23 | ECX | 02 | N | ECX | 101460582 |
| 20165813 | 20063520 | 1.71 | 92 | Neo-adjuvant (N) | 2017-09-04 | 2017-09-04 | ECX | N | N | ECX | 100739701 |
| 20165817 | 20063521 | 1.65 | 67.9 | Neo-adjuvant (N) | 2017-08-23 | 2017-09-12 | ECX | N | N | ECX | 100748243 |
| 20165827 | 20063522 | 1.7 | 92 | Palliative (P) | null | 2017-09-25 | ECX | N | N | ECX | 100772206 |
| 20165832 | 20063523 | 1.6 | 41.8 | Adjuvant (A) | 2017-11-04 | 2017-11-19 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101127584 |
| 20165842 | 20063524 | 1.63 | 69 | Adjuvant (A) | 2019-09-28 | 2019-10-11 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100289704 |
| 20165844 | 20063525 | 1.69 | 58 | Adjuvant (A) | 2018-03-17 | 2018-03-25 | Gemcitabine + Capecitabine | N | Y | CAPECITABINE + GEMCITABINE | 100704559 |
| 20165849 | 20063526 | 1.42 | 67.4 | Neo-adjuvant (N) | 2020-03-05 | 2020-03-17 | ECX | N | N | ECX | 101852847 |
| 20165852 | 20063527 | null | null | Adjuvant (A) | 2016-10-03 | 2016-10-30 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101185237 |
| 20165857 | 20063528 | 1.71 | 79.9 | null | 2016-03-11 | 2016-03-25 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101305062 |